Inclisiran - Wikipedia
https://en.wikipedia.org/wiki/Inclisiran
OverviewMedical usesDiscovery and mechanism of actionHistorySociety and cultureFurther readingExternal linksInclisiran, sold under the brand name Leqvio, is a medication used for the treatment of high low-density lipoprotein (LDL) cholesterol and for the treatment of people with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk-equivalents, and heterozygous familial hypercholesterolemia (HeFH). It is a small interfering RNA (siRNA) that acts as an inhibitor of a proprotein convertase, specifically, inhibiting translation of the protein PCSK9. Pregnancy category: AU: B1 Other names: ALN-PCSsc, ALN-60212 Trade names: Leqvio
Pregnancy category: AU: B1
Other names: ALN-PCSsc, ALN-60212
Trade names: Leqvio
DA: 18 PA: 89 MOZ Rank: 55